Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Cipla

    Tag: Cipla

    You Searched For "Cipla"
    Cipla gets USFDA final approval for generic version of Proventil HFA Inhalation Aerosol

    Cipla gets USFDA final approval for generic version of Proventil HFA Inhalation Aerosol

    Medical Dialogues Bureau10 April 2020 4:30 AM GMT
    Mumbai: Cipla Limited has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate...
    Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus

    Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus

    Medical Dialogues Bureau5 April 2020 9:11 AM GMT
    Mumbai: Cipla Limited has announced the successful completion of the Phase-3 clinical end-point study for fluticasone propionate and salmeterol...
    NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

    NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

    Medical Dialogues Bureau29 March 2020 7:49 AM GMT
    New Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
    Cipla gets USFDA final nod for Esomeprazole ANDA for Oral Suspension

    Cipla gets USFDA final nod for Esomeprazole ANDA for Oral Suspension

    Medical Dialogues Bureau27 March 2020 7:21 AM GMT
    Cipla's Esomeprazole for Oral Suspension 10mg, 20mg and 40mg is an AB-rated generic therapeutic equivalent version of AstraZeneca Pharmaceutical's ...
    Cipla joins hands with CSIR-IICT to develop coronavirus drug

    Cipla joins hands with CSIR-IICT to develop coronavirus drug

    Medical Dialogues Bureau19 March 2020 6:40 AM GMT
    Hyderabad: Hyderabad-based CSIR-Indian Institute of Chemical Technology (IICT) has tied up with pharmaceutical giant Cipla to work on the...
    Dr VG Somani DCGI releases IPA guidelines on Market Complaints.

    Dr VG Somani DCGI releases IPA guidelines on Market Complaints.

    Medical Dialogues Bureau2 March 2020 5:00 AM GMT
    The guidelines were released at the recently concluded India Pharmaceutical Forum
    NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details

    NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details

    Farhat Nasim17 Nov 2019 7:38 AM GMT
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    Medical Dialogues Bureau15 Nov 2019 10:59 AM GMT
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA fixes retail price of 14 drug formulations; Details

    NPPA fixes retail price of 14 drug formulations; Details

    Farhat Nasim13 Nov 2019 5:53 AM GMT
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Cipla acquires novel anti-infective Elores to further antimicrobial stewardship in critical care in India

    Cipla acquires novel anti-infective Elores to further antimicrobial stewardship in critical care in India

    Medical Dialogues Bureau18 Oct 2019 8:20 AM GMT
    Mumbai: Cipla Limited announces the acquisition of a novel and patented anti-infective product, Elores, from Venus Remedies Limited ("VRL") for the...
    Cipla gets 12 USFDA observations for Goa facility

    Cipla gets 12 USFDA observations for Goa facility

    Medical Dialogues Bureau30 Sep 2019 9:45 AM GMT
    "The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019,"...
    Cipla launches skin treatment Daptomycin Injection in US

    Cipla launches skin treatment Daptomycin Injection in US

    Medical Dialogues Bureau27 Sep 2019 8:23 AM GMT
    Drug firm Cipla on Wednesday said it has launched Daptomycin Injection, used for treating complicated skin infections, in the US market. Daptomycin...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok